Log in
Enquire now
‌

US Patent 10106500 Selective androgen receptor modulators (SARMs) and uses thereof

Patent 10106500 was granted and assigned to Ligand Pharmaceuticals on October, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Ligand Pharmaceuticals
Ligand Pharmaceuticals
0
Current Assignee
Ligand Pharmaceuticals
Ligand Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
101065000
Patent Inventor Names
Lin Zhi0
Date of Patent
October 23, 2018
0
Patent Application Number
155908840
Date Filed
May 9, 2017
0
Patent Primary Examiner
‌
Brian E McDowell
0
Patent abstract

Provided herein are compounds, such as compounds of Formula I, that bind to androgen receptors and/or modulate activity of androgen receptors. Also provided are methods for making and using such compounds. Also provided are compositions including such compounds and methods for making and using such compositions.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10106500 Selective androgen receptor modulators (SARMs) and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.